Coronary Angioplasty Market
Report ID: SQMIG35D2406
Report ID: SQMIG35D2406
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35D2406 |
Region:
Global |
Published Date: March, 2026
Pages:
157
|Tables:
88
|Figures:
76
Global Coronary Angioplasty Market size was valued at USD 897.9 Million in 2024 and is poised to grow from USD 967.94 Million in 2025 to USD 1765.21 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
Growing prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, rising geriatric population, advancements in stent technologies, and improving healthcare infrastructure are driving sales of coronary angioplasty procedures and devices. Sophisticated technologies, such as intravascular imaging and fractional flow reserve, are helping to provide more precise diagnosis and treatment, thus reducing the need for repeat procedures.
In emerging markets, an increase in cardiovascular screening programs and better reimbursement policies are driving procedure volumes, while in developed markets, radial access technologies are reducing recovery times and increasing patient throughput. These technologies are helping healthcare providers, manufacturers, and patients by providing better patient outcomes and increasing market opportunities. Growing burden of ischemic heart disease across the world coupled with increasing awareness regarding early diagnosis and treatment are expected to primarily drive coronary angioplasty market growth. Continuous technological innovation combined with evolving clinical practices are also creating new business scope for coronary angioplasty equipment manufacturers.
On the contrary, high procedural costs, risks associated with complications, limited access to advanced healthcare in developing regions, stringent regulatory approvals, and reimbursement challenges are predicted to hamper coronary angioplasty market penetration across the study period.
How is AI Improving Clinical Outcomes in the Coronary Angioplasty Market?
Artificial intelligence plays a vital role in improving clinical outcomes in coronary angioplasty, including diagnosis, planning, and guidance during the procedure. Some of its features include AI-based imaging, which helps in identifying plaque composition, and tools that aid in determining what needs to be treated during the procedure. For instance, AI platforms enable the generation of 3D models and FFR-like calculations, ensuring accuracy and precision during stent sizing and positioning. CT-based planning and angiography physiological analysis enable doctors to obtain more information before a procedure, such as what has been mentioned above.
Market snapshot - 2026-2033
Global Market Size
USD 897.9 Million
Largest Segment
Percutaneous Coronary
Fastest Growth
Percutaneous Coronary
Growth Rate
7.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
The coronary angioplasty market is segmented by procedure type, device type, end user, and region. Based on procedure type, the market is segmented into percutaneous coronary and coronary artery bypass. Based on device type, the market is segmented into stents and angioplasty balloons. Based on end user, the market is segmented into hospitals, cardiac clinics, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The percutaneous coronary segment is forecasted to spearhead the global coronary angioplasty market revenue generation in the future. The minimally invasive approach of this procedure reduces procedural trauma and enables quicker recovery, which cements its dominance. Ongoing enhancements in device compatibility and lesion-specific approaches are helping to improve success rates and surgeon confidence, while reimbursement pathways and guideline acceptance are helping to ensure consistent clinical adoption, further solidifying the product’s position in treatment algorithms and the market’s preference.
However, coronary artery bypass is emerging as the fastest growing segment as per this coronary angioplasty industry analysis. Complex multivessel disease and certain patient profiles require surgical revascularization thereby creating new opportunities. Advancements in techniques, hybrid techniques, and perioperative care expand the pool of candidates, and this drives hospital systems to improve their capabilities and training, thus sustaining the need for complete cardiac surgical care.
The stents segment is projected to account for the largest global coronary angioplasty market share going forward. Progressive drug eluting and scaffold technologies directly tackle restenosis and support vessel remodeling, which makes them a preferred choice for cardiac interventions. Ongoing advances in material science and coating technologies enhance biocompatibility and patency results, and the availability of deployment tools and clinician familiarity with the recommendations ensure continued adoption, reinforcing the position of stents as an essential device type in the angioplasty market.
Angioplasty balloons are also being recognized as the most promising and rapidly growing device type, driven by the need for specialty balloons to treat lesions and drug-coated balloons to expand the treated lesion sizes. The improved deliverability and safety profile in complex cases, along with the potential to use them in conjunction with other modalities, are driving the adoption and creating opportunities for innovation and investment.
To get detailed segments analysis, Request a Free Sample Report
Advanced clinical infrastructure, concentrated industry presence, and a strong innovation ecosystem helps North America emerge as the dominant region for coronary angioplastycompanies. Additionally, larger medical device manufacturers have significant R&D programs and partnerships with universities and other providers of care, which expeditesrefinement of technologies. Furthermore, North America has an established supply chain and highly trained interventional cardiologists that enable the rapid dissemination of best practices and guidelines and support continued market leadership and overall market demand for innovative coronary angioplasty products and services. North America also has a favorable regulatory and reimbursement environment which provides for rapid commercialization of newly developed products and services leading to wide-scale clinical use of these products and services.
High concentration of leading device manufacturers, extensive clinical research activity, and broad access to advanced interventional facilities allows the United States to emerge as a key market in this region. Reimbursement policies and well-defined protocols are conducive to the adoption, and the partnerships between device companies and academic centers are also cementing the dominance of the country. Early adoption of coronary angioplasty solutions is backed by developed reimbursement frameworks and established care pathways.
Publicly funded healthcare model with regional centers of excellence that prioritize equitable access and outcomes are supporting steady coronary angioplasty demand in Canada. Collaborative projects between hospitals and industry aim at modifying technology according to regional needs. Access and service delivery issues in rural and regional areas are considered. Expanding clinical networking and training is also promoting adoption of coronary angioplasty solutions in the country.
Robust clinical expertise across national health systems, increasing emphasis on minimally invasive cardiovascular care, and coordinated regulatory and reimbursement mechanisms support steady demand for coronary angioplasty across Europe. Regional production sources and global suppliers have developed strong distribution networks. Policies aim to improve the care of patients by improving cardiovascular outcomes and decreasing the amount of invasion associated with cardiovascular procedures; therefore, these policies help to advance the transition to new technologies, such as advanced angioplasty technique and additional imaging.
Clinician collaboration across borders and with payers and manufacturers serves to increase the spread of best practices. Countries have many unique market characteristics that allow for rapid growth by combining fund allocations to enhance infrastructure and create additional capacity for performing procedures and using devices.
A robust medical technology manufacturing base and a network of high-volume cardiac centers support high coronary angioplasty demand in Germany. Reimbursement systems and hospital infrastructure enable the adoption of innovative technology and procedural imaging. Training and expertise ensure high levels of competency in complex procedures. Emphasis on quality of care, technology validation, and alignment between manufacturers and healthcare providers is high in the country.
coronary angioplasty demand is rising rapidly in the United Kingdom on the back of health system initiatives to expand capacity, streamline pathways, and adopt cost effective technologies. Procurement through the public sector, coupled with strategic investments in interventional cardiology facilities, is driving the adoption of new technologies and associated products. Joint initiatives between academic institutions and industry players are facilitating the evaluation and dissemination of novel coronary angioplasty practices.
Concentrated efforts to modernize cardiac care facilities and integrate innovative device options within clinical pathways support steady coronary angioplasty demand in France. National clinical networks and hospital-level initiatives facilitate pilot projects for new coronary angioplasty solutions. Reimbursement and procurement factors influence market adoption, while training and specialist development programs enhance angioplasty procedures.
Growing healthcare investment, capacity building, and strategic industry development are helping create new business scope in Asia Pacific. Expansion of tertiary care facilities and advancements in clinical training programs increase procedural productivity. International as well as local manufacturers are developing manufacturing and distribution capacity to supply regional demand. In addition, Regulatory Expansion of tertiary care facilities and advancements in clinical training programs increase procedural productivity. International as well as local manufacturers are developing manufacturing and distribution capacity to supply regional demand.
In addition, Regulating order to enhance the Regional Evidence Base for technologies. Cost-sensitivity and innovation in the development of new medical technologies and the adaptation of existing devices for use across multiple care settings is providing the means to support broader implementation of Interventional Cardiology in Regionally and Globally. Global Suppliers working in partnership with Regional Stakeholders accelerate the transfer of Technology and Services between Both Metropolises and Secondary Markets.
Coronary pathways have matured, allowing quicker entry into the marketplace once approved technology becomes available. Rising collaborative clinical research initiatives is also enhance the regional evidence base for technologies. Cost-sensitivity and innovation in the development of new medical technologies and the adaptation of existing devices for use across multiple care settings is providing the means to support broader implementation of interventional cardiology in countries such as China, Japan, and India. Global suppliers working in partnership with regional stakeholders accelerate the transfer of technology and services between both metropolises and secondary markets.
High technological sophistication and a strong domestic medtech sector promote the demand for advanced coronary angioplasty solutions in Japan. Cardiac centers are well established, with a high level of experience among interventional cardiologists. These factors contribute to the acceptance of refined technology. The regulatory and clinical research infrastructure is designed to provide thorough testing of emerging technologies.
Rapid clinical adoption and a dynamic domestic manufacturing ecosystem that supports both local use and export drives coronary angioplasty adoption across South Korea. Competitive domestic suppliers are also supporting cost-effective solutions. Clinical expertise and integration of technology are driving increasing levels of procedure-based capabilities. Domestic centers of excellence in urban-based healthcare facilities are driving early adoption of technology, with focused training programs and industry collaboration also supporting growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence of Cardiovascular Disease
An increased incidence rate of CVD leads to an increased number of patients that need to be treated, hence boosting the need for coronary angioplasty procedures and devices. The increased number of patients with ischemic conditions leads to the use of minimally invasive percutaneous techniques, which have the advantage of short recovery times and the ability to target the affected areas, hence boosting the need for cath lab equipment and devices. The increased awareness among physicians and patients leads to an increased number of procedures, hence boosting the market through the continued need for the procedures.
Advancements in Device Technology
The continuous advancement of angioplasty technology and other technologies used as adjuncts to angioplasty also plays a significant role in stimulating the angioplasty balloon market, as these advancements make the procedure and the technology itself more effective and boost the confidence of medical professionals, resulting in increased demand. The advancement of angioplasty technology also plays a significant role in stimulating the angioplasty balloon market, as these advancements make the technology and the procedure itself more effective and boost the confidence of medical professionals, resulting in increased demand.
High Procedure and Device Costs
The high costs related to the coronary angioplasty procedures and the equipment are the major factors that are limiting the market growth, as the high costs are acting as an inhibitor and are affecting the market growth, especially in areas where the reimbursement is less and the budget is tight. The high capital costs related to the cath lab equipment and the consumables are also acting as an inhibitor and are affecting the market growth, especially in areas where the budget is tight, and the affordability of the patients is high, thereby tempering the growth and making the stakeholders focus on cost containment.
Limited Reimbursement and Coverage
Inconsistency and lack of proper reimbursement for coronary angioplasty treatments and related devices act as a barrier to the growth of the market, as uncertainty exists among healthcare providers and patients regarding proper reimbursement for such treatments and devices. Lack of proper and complete reimbursement for new technologiesassociated with coronary angioplasty may result in a lack of willingness among healthcare providers to implement such technologies, which ultimately hampers coronary angioplasty market outlook.
Request Free Customization of this report to help us to meet your business objectives.
Competitive landscape in the global coronary angioplasty market centers on device differentiation for complex lesions, with calcified lesion management and procedural automation driving rivalry. Companies execute acquisitions and strategic deals to add robotics or IVL capabilities, for example Siemens Healthineers acquisition of Corindus. Shockwave Medical’s IVL commercialization and reimbursement progress has accelerated adoption. Startups leverage novel lithotripsy and imaging to pressure incumbents.
Imaging and Physiology Integration
Complex Lesion Treatment Focus
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and growing geriatric population are anticipated to drive the demand for coronary angioplasty going forward. However, high procedural costs, risk of complications, and limited access to advanced healthcare facilities in developing regions are slated to slow down the adoption of coronary angioplasty in the future. North America is slated to spearhead the demand for coronary angioplasty owing to advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong reimbursement frameworks. Integration of AI-driven imaging, use of physiology-based assessment tools, and advancements in stent technologies are anticipated to be key trends driving the coronary angioplasty sector in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 897.9 Million |
| Market size value in 2033 | USD 1765.21 Million |
| Growth Rate | 7.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Coronary Angioplasty Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Coronary Angioplasty Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Coronary Angioplasty Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Coronary Angioplasty Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Coronary Angioplasty Market size was valued at USD 897.9 Million in 2024 and is poised to grow from USD 967.94 Million in 2025 to USD 1765.21 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
Key vendors in the Coronary Angioplasty Market include major medical device and healthcare companies such as Medtronic, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson, Terumo Corporation, B. Braun SE, BIOTRONIK, Cook Medical, and Cardinal Health, which play a significant role in developing angioplasty balloons, stents, and related technologies.
The key driver of the Coronary Angioplasty Market is the rising prevalence of cardiovascular diseases, particularly coronary artery disease. Increasing aging population, sedentary lifestyles, and growing adoption of minimally invasive procedures are further boosting demand for angioplasty treatments worldwide.
A key market trend in the Coronary Angioplasty Market is the growing adoption of advanced stent technologies, including drug-eluting and bioresorbable stents, for treating coronary artery disease. Additionally, there is an increasing shift toward minimally invasive and outpatient procedures to improve recovery and reduce hospital stays.
North America accounted for the largest share in the Coronary Angioplasty Market, driven by a high prevalence of coronary artery disease, advanced healthcare infrastructure, strong adoption of minimally invasive procedures, and availability of technologically advanced angioplasty devices.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
